|Podcasts|March 24, 2022

The Nutritional Outlook Podcast Episode 9: What does new FDA leadership mean for the dietary supplement industry?

In this episode, the Nutritional Outlook editors interview Robert Durkin, Of Counsel, for Arnall Golden Gregory LLP’s FDA and Healthcare practices. Previously, Durkin worked as the acting director and deputy director of the Office of Dietary Supplement Programs, in the FDA’s Center for Food Safety and Applied Nutrition. Given Durkin’s experience at FDA, he is well-qualified to provide some insights into how the leadership of FDA’s recently confirmed commissioner Robert Califf, MD, may affect the dietary supplement industry.

Related to this article

SupplySide Global Vitaquest
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
Laurentia Bliss
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Klaus Neumann
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.